Hingorani Sangeeta, Pao Emily, Schoch Gary, Gooley Ted, Schwartz George J
Seattle Children's Hospital, University of Washington Seattle, Washington; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington; and
Seattle Children's Hospital, University of Washington Seattle, Washington;
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):601-10. doi: 10.2215/CJN.06470614. Epub 2015 Feb 25.
Formal evaluation of kidney function before and after hematopoietic cell transplant is important to determine conditioning regimens, type of transplant, and medication dosing. Serum creatinine and estimating equations may not accurately assess kidney function.
DESIGN, STUDY, PARTICIPANTS, & MEASUREMENTS: Existing estimating equations for GFR were compared with an iohexol measure of GFR in a prospective cohort study of 50 patients undergoing hematopoietic cell transplant and subsequent care at the Fred Hutchinson Cancer Research Institute from 2009 to 2013. Patients underwent iohexol GFR, serum creatinine, and cystatin C determination at baseline and day 100 posthematopoietic cell transplant. Iohexol GFR measurements were compared with the CKD Epidemiology Collaboration, Inker CKD Epidemiology Collaboration cystatin C with and without serum creatinine, Modification of Diet in Renal Disease, and Cockcroft-Gault estimating equations using Bland-Altman analysis and McNemar's test. The iohexol measurements were also compared with blood samples collected simultaneously on filter paper.
Mean differences between iohexol GFR and eGFR on the basis of Bland-Altman analyses ranged from -20.6 to +15.4 ml/min per 1.73 m(2) at baseline and -12.7 to +12.9 ml/min per 1.73 m(2) at day 100. The CKD Epidemiology Collaboration and Modification of Diet in Renal Disease estimating equations classified 64% of patients with a GFR<90 at baseline compared with 38% by iohexol GFR (P=0.003 and P<0.01, respectively). No statistically significant differences were seen at day 100. The filter paper GFR had a mean difference of 0 at baseline and 5.9 at day 100. Additionally, 21%-37% and 57%-89% of eGFRs were within 10% and 30%, respectively, of the iohexol GFR at baseline, and 16%-34% and 72%-84% were within 10% and 30%, respectively, of the iohexol GFR at day 100; 98% of the filter paper estimates at baseline were within 30%, and 46% were within 10% of iohexol GFR.
The estimating equations are neither accurate nor precise in the hematopoietic cell transplant population, and clinical decision may require measurement of GFR.
造血细胞移植前后对肾功能进行正式评估,对于确定预处理方案、移植类型及药物剂量十分重要。血清肌酐及估算方程可能无法准确评估肾功能。
设计、研究、参与者与测量:在一项前瞻性队列研究中,将现有的肾小球滤过率(GFR)估算方程与碘海醇测量的GFR进行比较。该研究纳入了2009年至2013年在弗雷德·哈钦森癌症研究中心接受造血细胞移植及后续治疗的50例患者。患者在基线期及造血细胞移植后第100天进行碘海醇GFR、血清肌酐及胱抑素C测定。使用布兰德-奥特曼分析和麦克尼马尔检验,将碘海醇GFR测量值与慢性肾脏病流行病学合作组、英克慢性肾脏病流行病学合作组(含或不含血清肌酐)、肾脏病饮食改良试验及考克伦-高尔特估算方程进行比较。碘海醇测量值还与同时采集在滤纸上的血样进行比较。
根据布兰德-奥特曼分析,基线期碘海醇GFR与估算肾小球滤过率(eGFR)的平均差值为每1.73 m² -20.6至 +15.4 ml/min,在第100天为每1.73 m² -12.7至 +12.9 ml/min。慢性肾脏病流行病学合作组及肾脏病饮食改良试验估算方程在基线期将64%的GFR<90的患者归类,而碘海醇GFR归类的比例为38%(P分别为0.003和P<0.01)。在第100天未见统计学显著差异。滤纸法GFR在基线期平均差值为0,在第100天为5.9。此外,基线期分别有21% - 37%和57% - 89%的eGFR在碘海醇GFR的10%和30%范围内,第100天分别有16% - 34%和72% - 84%在该范围内;基线期98%的滤纸法估算值在碘海醇GFR的30%范围内,46%在10%范围内。
估算方程在造血细胞移植人群中既不准确也不精确,临床决策可能需要测量GFR。